Actively Recruiting
IVIG Trial for the Treatment of Bronchopulmonary Dysplasia
Led by International Peace Maternity and Child Health Hospital · Updated on 2026-04-01
20
Participants Needed
1
Research Sites
137 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
It is intended to examine the efficacy and safety of intravenous immunoglobulin(IVIG) for the bronchopulmonary dysplasia in preterms. Participants will received continuous infusion IVIG 1 g/kg/day for the first 2 days, 0.5 g/kg/day for next 3 days (total does 3.5 g/kg), repeatable if necessary.
CONDITIONS
Official Title
IVIG Trial for the Treatment of Bronchopulmonary Dysplasia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Gestational age between 25 weeks and 29 weeks + 6 days
- Admission within 24 hours after birth
- Clinical symptoms and chest X-ray results highly suspect bronchopulmonary dysplasia, including respiratory signs developing days or weeks after birth such as shortness of breath, cyanosis, pulmonary rales, intermittent hypoxic attacks, and chronic oxygen dependence
- Chest X-ray showing at least one of the following: lung texture thickening or ground glass opacity in early stage, diffuse lung texture blurred, lung hyperinflation, increased linear density shadows, or increased triangular density shadows under the pleura
- Normal full-term newborn without history of severe lung diseases, birth asphyxia, hypoxic-ischemic encephalopathy, or other conditions affecting respiratory, nervous, or other systems development
You will not qualify if you...
- Major congenital anomalies such as congenital heart disease, craniocerebral deformity, structural respiratory abnormalities, or hereditary metabolic diseases
- Chromosomal defects including trisomy 13, 18, or 21
- Severe intracranial hemorrhage
- Multiple organ failure
- Severe lung infections
- Other conditions deemed unsuitable for participation by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
International Peace Maternity and Child Health Hospital
Shanghai, Shanghai Municipality, China
Actively Recruiting
Research Team
F
Fu Xuemei
CONTACT
L
Li Dan
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here